© Copyright 2026, All Rights Reserved
AI-powered bone marrow analysis for blood cancer and drug discovery
Predict blood cancer progression from routine biopsy images; Identify morphological patterns linked to adverse events in clinical trials; Quantify fibrosis levels in bone marrow samples; Support drug development by forecasting patient response; Enable personalized treatment planning for hematological malignancies; Analyze bone marrow changes in autoimmune diseases and aging; Validate treatment efficacy in clinical audits
Working with leading cancer centers and major biopharma companies; Focus on blood cancers with 90% drug failure rates; Platform built at Oxford University and Oxford Science Enterprises; World's largest library of annotated bone marrow images; Validated clinical data context for all AI outputs